JEM Research LLC
Atlantis, Florida, United States
Doctor in Atlantis, Florida
130 John F Kennedy Dr STE 203, Lake Worth, FL 33462
About JEM Research LLC
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at JEM Research LLC
During the past decade, JEM Research LLC conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 9 clinical trials were completed, i.e. on
average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 7 clinical trials were completed. i.e. 77.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-05-01
2017-07-19
Completed
475
Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
2000-09-01
Unknown status
Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer
2001-07-01
2010-09-01
Completed
1,030
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-11-03
2025-12-01
Active, not recruiting
2,672
S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
2003-10-01
2016-09-01
Completed
257
Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer
2002-07-01
2016-08-22
Completed
162
Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2005-05-01
Completed
520
Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI)
2004-04-01
2007-05-01
Completed
5,745
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "JEM Research LLC" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Pfizer" with 4 trials
sponsored, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored, "Genentech, Inc." with 2 trials sponsored and "Impax Laboratories, LLC"
with 2 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "JEM Research LLC"
#1 collaborator was "Pfizer" with 3 trials as a collaborator and "Prothena Biosciences Limited" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at JEM Research LLC
According to Clinical.Site data, the most researched conditions in "JEM Research LLC" are
"Alzheimer Disease" (6 trials), "Alzheimer's Disease" (6 trials), "Alzheimers Disease" (2 trials), "Osteoarthritis" (2 trials) and "Cognitive Dysfunction" (1 trials). Many other conditions were trialed in "JEM Research LLC" in a lesser frequency.
Clinical Trials Intervention Types at JEM Research LLC
Most popular intervention types in "JEM Research LLC" are "Drug" (19 trials), "Biological" (4 trials) and "Other" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (14 trials), "Gantenerumab" (4 trials), "Bapineuzumab 0.5 mg/kg" (3 trials), "Bapineuzumab 1.0 m/kg" (2 trials) and "Placebo Control" (2 trials). Other intervention names were less common.
Clinical Trials Genders at JEM Research LLC
The vast majority of trials in "JEM Research LLC" are
23 trials for "All" genders.
Clinical Trials Status at JEM Research LLC
Currently, there are NaN active trials in "JEM Research LLC".
undefined are not yet recruiting,
3 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in JEM Research LLC,
1 suspended trials,
and 10 terminated clinical trials to date.
Out of the total trials that were conducted in JEM Research LLC, 1 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 16 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".